For citations:
Nozdrina E.V., Mazalev D.A., Rogozina D.R., Zhivoderov S.P., Lyagoskin I.V., Shukurov R.R. Development and validation of an analytical procedure for the determination of residual protein A in active substances of therapeutic monoclonal antibodies. Biological Products. Prevention, Diagnosis, Treatment. 2024;24(1):32-45. (In Russ.) https://doi.org/10.30895/2221-996X-2024-24-1-32-45
Email this article 